1. <p id="uxtij"></p>

        Search for the keyword:
           
        What is Apixaban?
        source:Vitalpharms Company Ltd.    Release date:2021/8/30 13:52:57
        Apixaban (ELIQUIS) is an oral selective activation factor X inhibitor, jointly developed by Pfizer and Bristol-Myers Squibb. Eliquis can prevent thrombosis, but the adverse effects of bleeding are lower than that of the old drug warfarin. It is used for thrombosis prevention in patients who have undergone hip or knee replacement surgery.

        Apixaban is a new type of oral anticoagulant, a new type of oral factor Xa inhibitor, and a drug used to prevent and treat blood clots. The recommended dose is 2.5 mg, taken orally twice a day, which can effectively prevent venous thromboembolism without increasing the risk of bleeding. There is no need for routine monitoring of coagulation function and no dose adjustment. Suitable for adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolic events (VTE)
        Previous:Basic introduction of dabigatran etexilate/
        Next:The role and efficacy of rivaroxaban tablets

        About Us
        Company Profile
        Culture
        Qualification
        Staff style
        Organization
        News
        Company News
        Industry news
        Media coverage
        Products
        Agent Products
        Intermediates
        Associated with the review and intermediates
        Animal health related products
        Merchants joined
        Industry Standard
        Quality certification
        Contact Us
        Vitalpharms Company Ltd.
        Add.: 2/F, 3# Buliding, 169 Shihua Rd. West, Zhuhai, Guangdong, China.
        Tel: +86-756-3326819/ 3221531
        Fax: +86-756-3326816
        E-MAIL: sales@m.zgyjjyzb.com
        Copyright©Vitalpharms Company Ltd.  Internet Drug Information Service Qualification Certificate: (Guangdong)- Non-operational -2023-0028   粵ICP備10097759號(hào)
        久久er热在这里只有精品85,一区二区三区四区不长视频,99re热亚洲无码中文,精品久久久久久亚洲女厕
        1. <p id="uxtij"></p>